José E. Velázquez Vega

This study uses spatial transcriptomics to analyze medulloblastoma tumor microenvironments, identifying high-risk features and spatial patterns linked to relapse.

This study shows ONC206 effectively kills medulloblastoma cells and extends survival in mouse models, supporting its potential as a new treatment for high-risk medulloblastoma.

This study shows that PRC2 maintains neural identity in cerebellar progenitors and medulloblastoma, but its disruption does not block medulloblastoma progression.

This study uses deep learning to predict cancer patient outcomes by integrating histology images and genomic data, showing improved performance over current clinical methods for glioma survival prediction.